Are There Warning Signs About Moderna's COVID-19 Vaccine Program?

In any discussion about the race to develop a vaccine against the novel coronavirus that causes COVID-19, Moderna (NASDAQ:MRNA) will almost certainly be mentioned. The biotech ranked among a select group of companies to receive significant funding as part of Operation Warp Speed, the U.S. government program created to accelerate COVID-19 vaccine development. It is without question one of the clear leaders in developing a COVID-19 vaccine candidate.